[1]张航 安景辉 石凤梧.极简式经导管主动脉瓣置换术的研究现状[J].心血管病学进展,2022,(9):812-814.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
 ZHANG Hang,AN Jinghui,SHI Fengwu.Minimalist Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(9):812-814.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.011]
点击复制

极简式经导管主动脉瓣置换术的研究现状()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年9期
页码:
812-814
栏目:
出版日期:
2022-09-25

文章信息/Info

Title:
Minimalist Transcatheter Aortic Valve Replacement
作者:
张航 安景辉 石凤梧
(河北医科大学第二医院心脏外科,河北 石家庄 050000)
Author(s):
ZHANG HangAN JinghuiSHI Fengwu
(Department of Cardiac Surgery,The Second Hospital of Hebei Medical University,Shijiazhuang 050000,Hebei,China)
关键词:
极简式经导管主动脉瓣置换术主动脉瓣狭窄
Keywords:
MinimalismTranscatheter aortic valve replacement Aortic stenosis
DOI:
10.16806/j.cnki.issn.1004-3934.2022.09.011
摘要:
当前经导管主动脉瓣置换术(TAVR)迅猛发展,该术式已成功成为治疗高龄、高危、外科手术禁忌患者主动脉瓣膜疾病的一线方案。随着TAVR水平的不断提高,人们对手术微创化、精细化的要求也在逐步提高。传统的标准化TAVR已不能满足当前介入瓣膜治疗发展的需要,繁琐的手术流程不但延长了患者的住院/手术时间,使住院成本大大提高,还可能增加相关不良事件的发生风险,影响患者的预后,TAVR流程优化大势所趋。极简式TAVR是指在保证手术安全性及有效性的前提下切实优化传统的TAVR流程,提高手术效率,实现最大程度上的微创化和精细化治疗的新型TAVR模式。现对极简式TAVR的研究现状做一综述。
Abstract:
Nowadays,transcatheter aortic valve replacement(TAVR) has developed rapidly and has successfully become the first-line treatment for aortic valve disease in elderly,high-risk and surgical contraindicated patients. With the continuous improvement of TAVR level,people’s requirements for minimally invasive and refined surgery are also gradually increasing. The traditional standardized TAVR can no longer meet the needs of the current development of interventional valve therapy. The cumbersome surgical process not only prolongs the hospitalization/operation time of patients,greatly increases the hospitalization cost,but also may increase the risk of related adverse events and affects the prognosis of patients. TAVR process optimization is the general trend. Minimalist TAVR refers to the optimization of the traditional TAVR process under the premise of ensuring the safety and effectiveness of surgery,improving the efficiency of surgery,and achieving minimally invasive and refined treatment to the maximum extent. This paper summarizes the research status of minimalist TAVR.

参考文献/References:

[1].Cribier A,Eltchaninoff H,Bash A,et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis:first human case description[J]. Circulation,2002,106(24):3006-3008.
[2].[2]中国医师协会心血管内科医师分会结构性心脏病专业委员会. 经导管主动脉瓣置换术中国专家共识(2020 更新版)[J]. 中国介入心脏病学杂志,2020,28(6):301-309.
[3].[3]Smith CR,Leon MB,Mack MJ,et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients[J]. N Engl J Med,2011,364(23):2187-2198.
[4].[4]Adams DH,Popma JJ,Reardon MJ,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis[J]. N Engl J Med,2014,370(19):1790-1798.
[5].[5]Thourani VH,Kodali S,Makkar RR,et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients:a propensity score analysis[J]. Lancet,2016,387(10034):2218-2225.
[6].[6]Leon MB,Smith CR,Mack MJ,et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med,2016,374(17):1609-1620.
[7].[7]Mack MJ,Leon MB,Thourani VH,et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients[J]. N Engl J Med,2019,380(18):1695-1705.
[8].[8]Popma JJ,Deeb GM,Yakubov SJ,et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients[J]. N Engl J Med,2019,380(18):1706-1715.
[9].[9]Babaliaros V,Devireddy C,Lerakis S,et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory(minimalist approach) versus hybrid operating room(standard approach):outcomes and cost analysis[J]. JACC Cardiovasc Interv,2014,7(8):898-904.
[10].[10]朱齐丰,刘先宝,王建安. 极简式经导管主动脉瓣置换术研究进展[J]. 中国医学前沿杂志(电子版),2018,10(1):11-14.
[11].Lauck SB,Wood DA,Baumbusch J,et al. Vancouver transcatheter aortic valve replacement clinical pathway:minimalist approach,standardized care,and discharge criteria to reduce length of stay[J]. Circ Cardiovasc Qual Outcomes,2016,9(3):312-321.
[12].[12]Barbanti M,Capranzano P,Ohno Y,et al. Early discharge after transfemoral transcatheter aortic valve implantation[J]. Heart,2015,101(18):1485-1490.
[13].[13]Omer MA,Smolderen K,Kennedy K,et al. Effect on 30-day readmissions after early versus delayed discharge after uncomplicated transcatheter aortic valve implantation(from the nationwide readmissions database)[J]. Am J Cardiol,2020,125(1):100-106.
[14].[14]Wood DA,Lauck SB,Cairns JA,et al. The vancouver 3M(multidisciplinary,multimodality,but minimalist) clinical pathway facilitates safe next-day discharge home at low-,medium-,and high-volume transfemoral transcatheter aortic valve replacement centers:the 3M TAVR study[J]. JACC Cardiovasc Interv,2019,12(5):459-469.
[15].[15]Alkhalil A,Lamba H,Deo S,et al. Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement[J]. Catheter Cardiovasc Interv,2018,91(2):345-353.
[16].[16]范嘉祺刘先宝郭宇超等. 第二天出院极简式经导管主动脉瓣置换术一例[J] . 中华心血管病杂志2021,49(5):510-512.
[17].[17]陈阳王墨扬牛冠男等. 中国首例完全局部麻醉且无镇静下极简式经导管主动脉瓣置换术[J] . 中国循环杂志,2021,36(10):1027-1030.
[18].赵振燕张洪亮张喆,等. 在单纯局部麻醉下行经导管主动脉瓣置换术可行性和安全性的初步研究[J] . 中国循环杂志,2022,37(4):341-347.
[19].刘新民,宋光远,滕思勇,等. 使用左心室导丝起搏技术行经导管主动脉瓣置换术联合经皮冠状动脉介入治疗一站式手术一例[J]. 中国循环杂志,2020,35(12):1250-1252.
[20].宋光远刘新民滕思勇等. 使用左心室导丝起搏技术行经导管主动脉瓣置换术[J] . 中华心血管病杂志2021,49(5):461-466.
[21].[21]刘新民姚晶董哲等. 使用单动脉入路技术行经导管主动脉瓣置换术三例[J] . 中国循环杂志,202237(4):421-424.

相似文献/References:

[1]于子凯 许海燕 刘庆荣 吴永健.合并常见疾病对经导管主动脉瓣置换术患者预后的影响[J].心血管病学进展,2019,(5):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
 YU Zikai,XU Haiyan,LIU Qingrong,et al.Influence of ommon Accompanied Diseases on Prognosis of Patients after Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2019,(9):697.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.009]
[2]邵美华 周玉强 王萌萌 王宝珠 马翔.经导管主动脉瓣置换术治疗二叶式主动脉瓣狭窄研究进展[J].心血管病学进展,2020,(11):1184.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[3]刘新民 宋光远 吴永健.左心室导丝起搏技术在经导管主动脉瓣置换术中的应用[J].心血管病学进展,2021,(4):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
 LIU Xinmin,SONG Guangyuan,WU Yongjian.Application of Left Ventricular Guidewire Pacing in Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2021,(9):289.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.001]
[4]李宗泽 何贵均 郑晓菲 蒋晖 刘汉雄.经导管主动脉瓣置换术后合并心房颤动的抗栓策略[J].心血管病学进展,2021,(10):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
 LI ZongzeHE GuijunZHENG XiaofeiJIANG HuiLIU Hanxiong.Optimal Antithrombotic Strategies after Transcatheter Aortic Valve Replacement in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(9):892.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.007]
[5]陈阳 赵庆豪 赵杰 吴永健.经导管主动脉瓣置换术时代慢性主动脉瓣反流诊治进展[J].心血管病学进展,2022,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
 CHEN Yang,ZHAO Qinghao,SONG Guangyuan,et al.Diagnosis and Treatment of Chronic Aortic Regurgitation in Transcatheter Aortic Valve Replacement Era[J].Advances in Cardiovascular Diseases,2022,(9):1.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.001]
[6]董一娜 雷芳芳 宋启煦 王晶 杨艳.经导管主动脉瓣置换术后死亡风险预测模型系统评价[J].心血管病学进展,2022,(1):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
 DONG Yina,LEI Fangfang,SONG Qixu,et al.Mortality Risk Prediction Models After Transcatheter?span>Aortic Valve Replacement:A Systematic Review[J].Advances in Cardiovascular Diseases,2022,(9):76.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.020]
[7]张木馨 李丽英 阮海燕 何森.经导管主动脉瓣置换术后抗栓治疗进展[J].心血管病学进展,2022,(6):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
 ZHANG Muxin,LI Liying,RUAN Haiyan,et al.Progress of Antithrombotic Therapy after?ranscatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(9):518.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.010]
[8]. 经导管主动脉瓣置换术术后抗栓治疗的研究进展 [J].心血管病学进展,2022,(7):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
 DUAN ZhenyaWU Yongjian.Antithrombotic Therapy After Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2022,(9):577.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[9]王卫卫 于子凯 吴永健 许海燕 刘庆荣.序贯综合心脏康复模式在经导管主动脉瓣置换术患者中应用现状[J].心血管病学进展,2022,(8):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
 WANG Weiwei,YU Zikai,WU YongjianXU HaiyanLIU Qingrong.The Status of Sequential Comprehensive Cardiac Rehabilitation in Patients?ndergoing Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2022,(9):673.[doi:10.16806/j.cnki.issn.1004-3934.2022.08.001]
[10]胡正 陈祥 洲陈静.经导管主动脉瓣置换术后冠状动脉阻塞的研究进展[J].心血管病学进展,2023,(5):402.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.005]
 HUZheng,CHENXiangzhou,CHENJing.Coronary Occlusion of Transcatheter Aortic Valve Replacement[J].Advances in Cardiovascular Diseases,2023,(9):402.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.005]

备注/Memo

备注/Memo:
收稿日期: 2022-05-02 基金项目: 2020年政府资助临床医学优秀人才培养项目(2020397)
更新日期/Last Update: 2022-10-24